Secondary Prevention of Cervical Cancer
Key Points
Key Points
- ASCO published its first guideline on secondary prevention of cervical cancer in 2016. This guideline updates the previous. New and altered recommendations for 2022 are identified; others remain the same as in 2016.
- Resource stratified guidelines provide recommendations given the level of resources in particular settings.
- Human papillomavirus (HPV) deoxyribonucleic acid (DNA) testing is recommended in all resource settings; visual inspection with acetic acid may be used in the basic setting.
- Women who are human immunodeficiency virus (HIV)-positive should be screened for HPV after diagnosis and twice as many times throughout their lifetime as those in the general population.
Resource Settings
...rce Settings
...work of Resource StratificationSetting Basic...
Screening/Triage/Management
...creening/Triage/Manageme...
Maximal Setting
...22: In maximal resource settings, cervical cancer...
...are ≥65 years of age who have had consist...
...ts of the HPV DNA test are positive, clinicians...
If triage results are abnormal (i.e....
...HPV test results are positive at the...
...omen who have received HPV and cytology co-testi...
...e results of the biopsy indicate t...
...ceive treatment for precursor lesi...
...hanced Sett...
...2022: In enhanced resource settings, cerv...
...there are two consecutive negative scr...
...are ≥65 years of age who have had c...
...ults of the HPV DNA test are positiv...
...age results are abnormal (i.e., ≥ASC-US o...
...V test results are positive at the repeat...
If the results of colposcopy and biopsy indic...
...fter women receive treatment for precursor l...
...imited Set...
...2022: Cervical cancer screening with HPV D...
...e with reflex cytology (quality assu...
...h visual inspection with acetic ac...
...If cytology triage results are abnormal (...
...: If HPV genotyping or VIA or VAT triage r...
...ts are positive at the repeat 12-month follow-...
...or treatment, clinicians should offer...
...n receive treatment for precursor l...
...sic Settin...
...22: Health systems in basic settings sh...
...n 2022: If the results of availabl...
New in 2022: If primary screening is VIA and...
...ive treatment for precursor lesions...
.... VIA versus VAT...
...igure 2. Secondary Prevention of Cer...
...Secondary Prevention of Cervical Cancer fo...
.... Secondary Prevention of Cervical Cancer for Wo...
...5. Secondary Prevention of Cervical Cance...
...ASCO believes that cancer clinical trials a...